Senseonics Holdings, Inc.

Senseonics Holdings, Inc.

Senseonics Holdings, Inc.

Overview
Date Founded

2015

Headquarters

20451 Seneca Meadows Parkway, Germantown, MD, 20876-7005, USA

Type of Company

Public

Employees (Worldwide)

191

Industries

Medical Products & Equipment
Electrical Products

Company Description

Senseonics Holdings, Inc. engages in the design, development, and commercialization of implantable continuous glucose monitoring system for people with diabetes. Its primary product is the brand Eversense, a gluscose monitoring device which includes sensor, smart transmitter, and mobile application. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Contact Data
Trying to get in touch with decision makers at Senseonics Holdings, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President & Chief Executive Officer

Chief Financial Officer & Principal Accounting Officer

Chief Operating Officer

Chief Medical Officer & Director

Vice President & General Manager, US Region

Vice President & General Manager, Global Commercial Operations

Vice President-Engineering, Research & Development

Vice President-Clinical Sciences

Human Resource Manager

Investor Relations Contact

Board of Directors

Affiliate Partner at Lindsay Goldberg, LLC

Director & Chief Medical Officer at Senseonics, Inc.

Partner, Healthcare at New Enterprise Associates

Chairman & Chief Executive Officer at TerSera Therapeutics LLC

President & Chief Executive Officer at Senseonics, Inc.

Founder at Taking Control of Your Diabetes

Managing Partner at Delphi Ventures, Inc.

Former Executive Vice President of Finance & Chief Financial Officer at Nordion (Canada), Inc.

Research Analyst, Small & Extended Small Cap Growth at Perimeter Capital Management LLC

Director at Senseonics Holdings, Inc.

Paths to Senseonics Holdings, Inc.
Potential Connections via
Relationship Science
You
Senseonics Holdings, Inc.
Recent Transactions
Details Hidden

Senseonics Holdings, Inc. issued . USD Common Stock

Details Hidden

Senseonics Holdings, Inc. issued . USD Common Stock

Details Hidden

Senseonics Holdings, Inc. issued . USD Common Stock

Insider Transactions
Details Hidden
Details Hidden
Details Hidden
Transaction Advisors
Escrow Agent

Advised onSenseonics Holdings, Inc. issued . USD Common Stock

Legal Advisor

Advised onSenseonics Holdings, Inc. issued . USD Common Stock

Underwriter

Advised onSenseonics Holdings, Inc. issued . USD Common Stock

Legal Advisor

Advised onSenseonics Holdings, Inc. issued . USD Common Stock

Legal Advisor

Advised onSenseonics Holdings, Inc. issued USD Common Stock

Legal Advisor

Advised onSenseonics Holdings, Inc. issued USD Common Stock

Advisors & Consultants
Advisor

Chief Financial Officer, Treasurer & Secretary at Lyra Therapeutics, Inc.

Advisor

Chief Financial & Corporate Development Officer at Lefteris Acquisition Corp.

Clients

Roche Holding ag Roche Personalised Healthcare – our mission The healthcare landscape is constantly changing. Patients, physicians and payers demand safer, more effective treatments, while investors search after robust and sustainable business models. Growing demand for highly effective, impactful medicines is being driven by an aging population, healthcare and economic pressures. But an influx of new technologies enables Roche to meet this need by offering innovative tests and medicines. These healthcare drivers have led us in one direction – ‘Roche Personalised Healthcare’. At Roche, ‘Personalised Healthcare’ is at the core of our business strategy

Key Stats and Financials As of 2019
Market Capitalization
$91.5M
Total Enterprise Value
$196M
Earnings Per Share
$-0.61
Revenue
$21.3M
Net Profit
$-116M
EBITDA
$-130M
EBITDAMargin
-608.71%
Total Debt
$119M
Total Equity
$-8.65M
Enterprise Value / Sales
9.21x
TEVNet Income
-1.7x
Debt TEV
0.61x
Three Year Compounded Annual Growth Rate Of Revenue
300.33%
Competitors
Abbott Laboratories Pharmaceuticals - Abbott Park, Illinois

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Medtronic Plc Medical Products & Equipment - Dublin, Irl

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist Cardiac Rhythm and Heart Failure, Coronary and Structural Heart, and Aortic and Peripheral Vascular divisions. The Minimally Invasive Technologies Group segment comprises Surgical Innovations and Respiratory, Gastrointestinal, and Renal divisions. The Restorative Therapies Group contains Spine, Brain, Specialty Therapies, and Pain Therapies divisions. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Roche Holding AG Pharmaceuticals - Basel, Switzerland

Roche Holding ag Roche Personalised Healthcare – our mission The healthcare landscape is constantly changing. Patients, physicians and payers demand safer, more effective treatments, while investors search after robust and sustainable business models. Growing demand for highly effective, impactful medicines is being driven by an aging population, healthcare and economic pressures. But an influx of new technologies enables Roche to meet this need by offering innovative tests and medicines. These healthcare drivers have led us in one direction – ‘Roche Personalised Healthcare’. At Roche, ‘Personalised Healthcare’ is at the core of our business strategy

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Senseonics Holdings, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Senseonics Holdings, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Senseonics Holdings, Inc..